Kunming Longjin Pharmaceutical Co Ltd (002750) — Cash Flow Reinvestment Rate
Kunming Longjin Pharmaceutical Co Ltd (002750) has a Cash Flow Reinvestment Rate of 146.78x as of December 2022, reinvesting CN¥127.33 Million (capex CN¥5.41 Million plus investments CN¥121.93 Million) from operating cash flow of CN¥867.54K. Check Kunming Longjin Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kunming Longjin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2011–2019)
Historical reinvestment intensity for Kunming Longjin Pharmaceutical Co Ltd across 9 annual periods. Explore 002750 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Kunming Longjin Pharmaceutical Co Ltd (2011–2019)
Year-by-year capital reinvestment analysis for Kunming Longjin Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Kunming Longjin Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 49.98x | CN¥202.07 Million | CN¥4.04 Million | CN¥7.07 Million | ▲ +399.9% |
| 2018 | 10.00x | CN¥316.91 Million | CN¥31.70 Million | CN¥15.53 Million | ▲ +1264.5% |
| 2017 | 0.73x | CN¥42.54 Million | CN¥58.06 Million | CN¥17.54 Million | ▼ -67.5% |
| 2016 | 2.25x | CN¥235.06 Million | CN¥104.24 Million | CN¥23.56 Million | ▼ -18.4% |
| 2015 | 2.76x | CN¥193.93 Million | CN¥70.19 Million | CN¥23.93 Million | ▲ +949.5% |
| 2014 | 0.26x | CN¥18.47 Million | CN¥70.16 Million | CN¥18.47 Million | ▼ -52.9% |
| 2013 | 0.56x | CN¥59.57 Million | CN¥106.46 Million | CN¥59.57 Million | ▼ -31.2% |
| 2012 | 0.81x | CN¥74.14 Million | CN¥91.16 Million | CN¥74.14 Million | ▼ -33.5% |
| 2011 | 1.22x | CN¥92.79 Million | CN¥75.90 Million | CN¥92.79 Million | — |